Almirall SA
MAD:ALM
Almirall SA
MAD:ALM
Price:
11.4
EUR
-1.38%
Market Closed
Market Cap:
€2.4B
Relative Value
The Relative Value of one
ALM
stock under the Base Case scenario is
10.63
EUR.
Compared to the current market price of 11.4 EUR,
Almirall SA
is
Overvalued by 7%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALM
Relative Value
Base Case
10.63
EUR
Overvaluation 7%
Multiples Across Competitors
ALM Competitors Multiples
Almirall SA Competitors
Almirall SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Almirall SA
MAD:ALM
|
2.4B EUR | 2.2 | 53.1 | 10.8 | 33.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
930.7B USD | 14.3 | 45.1 | 30.4 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.6B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.9B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.7B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.2B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.1B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
